There is currently no text in this page. You can search for this page title in other pages, or search the related logs, but you do not have permission to create this page.
Category:A61K48/00
Jump to navigation
Jump to search
Pages in category "A61K48/00"
The following 16 pages are in this category, out of 16 total.
1
- 18167598. Compositions and Methods of Treating Ocular Diseases simplified abstract (THE REGENTS OF THE UNIVERSITY OF CALIFORNIA)
- 18255951. TREATMENT OF CONGENITAL STATIONARY NIGHT BLINDNESS USING GENE THERAPY simplified abstract (CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE)
- 18270014. Suppression-Replacement Gene Therapy simplified abstract (Mayo Foundation for Medical Education and Research)
- 18325332. Systemic Delivery of Polypeptides simplified abstract (Massachusetts Institute of Technology)
- 18449940. DEAD GUIDES FOR CRISPR TRANSCRIPTION FACTORS simplified abstract (Massachusetts Institute of Technology)
2
- 20240009284. METHOD AND COMPOSITION FOR TREATING ARGINASE 1 DEFICIENCY simplified abstract (Aerase, Inc.)
- 20240016894. METHODS AND MATERIALS FOR AMELIORATING CREATINE DEFICIENCY DISORDERS simplified abstract (The Regents of the University of California)
- 20240033378. ANTISENSE OLIGOMERS FOR TREATMENT OF NON-SENSE MEDIATED RNA DECAY BASED CONDITIONS AND DISEASES simplified abstract (STOKE THERAPEUTICS, INC.)
B
- Blockchain patent applications on April 11th, 2024
- Blockchain patent applications on April 18th, 2024
- Blockchain patent applications on February 1st, 2024
- Blockchain patent applications on January 11th, 2024
- Blockchain patent applications on January 18th, 2024
- Blockchain patent applications on March 28th, 2024
- Blockchain patent applications on March 7th, 2024